3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
19
Phase 2
11
Phase 1
11
Phase 1/2
3
Phase EARLY_PHASE1
1
Phase 4
1
Phase 3
1
Phase 2/3
1
Status
Completed
94
Unknown
19
Terminated
13
Active not recruiting
11
Recruiting
10
Withdrawn
5
Suspended
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
41
Carcinoma, Non-Small-Cell Lung
27
Colorectal Neoplasms
17
Neoplasms
13
Prostatic Neoplasms
11
Nasopharyngeal Carcinoma
11
Lung Neoplasms
11
Carcinoma, Hepatocellular
11
Multiple Myeloma
9
Leukemia, Myeloid, Acute
9
Stomach Neoplasms
8
Small Cell Lung Carcinoma
8
Ovarian Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Rectal Neoplasms
7
Esophageal Neoplasms
7
Triple Negative Breast Neoplasms
6
Pancreatic Neoplasms
6
Non-Muscle Invasive Bladder Neoplasms
6
Neoplasm Metastasis
6
Esophageal Squamous Cell Carcinoma
6
Uterine Cervical Neoplasms
5
Recurrence
5
Glioblastoma
5
Colonic Neoplasms
5
Carcinoma, Renal Cell
5
Brain Neoplasms
5
Adenocarcinoma
5
Urinary Bladder Neoplasms
4
Lymphoma, Follicular
4
Interventions
blinatumomab
1
CVAD protocol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Not yet recruiting
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Clear all
NCT07223190
2026-03-04
AUDAX
Amgen
Phase 3
Not yet recruiting
560 enrolled